Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $97
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Jason Bednar maintains an Overweight rating on Merit Medical Systems (MMSI) and raises the price target from $95 to $97.

May 01, 2024 | 1:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler maintains an Overweight rating on Merit Medical Systems and raises the price target from $95 to $97.
The increase in the price target by Piper Sandler suggests a positive outlook on Merit Medical Systems' stock, likely due to strong performance or favorable market conditions. This endorsement from a reputable analyst could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100